Chronic kidney disease. N18.6
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Written consent and willingness to participate in the study Age between 18 and 75 years Undergoing hemodialysis for at least 3 months Receiving chronic dialysis at least three times a week
Exclusion criteria
Exclusion criteria: Participation in a concurrent research study Diagnosis of malignant tumors Suffering from psychiatric disorders and mental retardation Suffering from severe acute infection (sepsis) during the study period Undergoing surgery Hospitalization for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Creatinine. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;Blood urea nitrogen (BUN). Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;CRP. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;Total cholesterol. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;Triglyceride. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;HDL- cholestrol. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;LDL-cholestrol. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;Sodium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit.;Potassium. Timepoint: Before the intervention, 12 weeks after the intervention. Method of measurement: biochemical kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences